Home › Breast Cancer
Breast Cancer clinical trials recruiting in the U.S.
671 studies for Breast Cancer are recruiting participants at sites across the United States.
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
Cities with the most studies
- New York City, NY134 studies
- Houston, TX126 studies
- Boston, MA110 studies
- Nashville, TN79 studies
- Los Angeles, CA71 studies
- Edison, NJ69 studies
- St. Louis, MO65 studies
- Queens, NY63 studies
- Durham, NC63 studies
- Chicago, IL58 studies
- Philadelphia, PA56 studies
- Dallas, TX54 studies
- Washington, DC47 studies
- Baltimore, MD47 studies
- Arlington, VA46 studies
- San Antonio, TX46 studies
- Baldwin Park, CA45 studies
- San Francisco, CA43 studies
- Tampa, FL43 studies
- Miami, FL42 studies
- Greenburgh, NY42 studies
- Rochester, MN42 studies
- Atlanta, GA41 studies
- San Diego, CA41 studies
- Seattle, WA40 studies
- Staten Island, NY40 studies
- Jacksonville, FL40 studies
- Columbus, OH39 studies
- New Rochelle, NY38 studies
- Pittsburgh, PA38 studies
- New Haven, CT37 studies
- Cleveland, OH35 studies
- East Norwalk, CT35 studies
- Detroit, MI34 studies
- Kansas City, MO34 studies
- Portland, OR32 studies
- Denver, CO28 studies
- Salt Lake City, UT27 studies
- Santa Monica, CA27 studies
- Minneapolis, MN27 studies
By state
- Alabama29 studies
- Alaska8 studies
- Arizona57 studies
- Arkansas17 studies
- California178 studies
- Colorado52 studies
- Connecticut46 studies
- Delaware9 studies
- District of Columbia29 studies
- Florida146 studies
- Georgia53 studies
- Hawaii12 studies
- Idaho6 studies
- Illinois81 studies
- Indiana35 studies
- Iowa23 studies
- Kansas27 studies
- Kentucky24 studies
- Louisiana23 studies
- Maine16 studies
- Maryland68 studies
- Massachusetts116 studies
- Michigan75 studies
- Minnesota68 studies
- Mississippi11 studies
- Missouri75 studies
- Montana13 studies
- Nebraska26 studies
- Nevada19 studies
- New Hampshire16 studies
- New Jersey93 studies
- New Mexico19 studies
- New York174 studies
- North Carolina90 studies
- North Dakota10 studies
- Ohio79 studies
- Oklahoma20 studies
- Oregon40 studies
- Pennsylvania92 studies
- Rhode Island14 studies
- South Carolina23 studies
- South Dakota20 studies
- Tennessee90 studies
- Texas177 studies
- Utah42 studies
- Vermont6 studies
- Virginia76 studies
- Washington53 studies
- West Virginia13 studies
- Wisconsin45 studies
- Wyoming3 studies
Recently updated studies
Study of AVZO-021 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05867251Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Sep 28, 2026 · NCT07619534EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer
Recruiting
Ages 20 to 89 · Women · Updated Sep 28, 2026 · NCT07704476CBD for Breast Cancer Primary Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06148038Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RecruitingObservational study
Ages 3 and older · All sexes · Updated Sep 28, 2026 · NCT01441089Genomic Services Research Program
RecruitingObservational study
1 Month – 105 Years · All sexes · Updated Sep 28, 2026 · NCT02595957Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment
Recruiting
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07553234Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
RecruitingPhase 2
Ages 18 to 72 · All sexes · Updated Sep 28, 2026 · NCT03412877A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05646862Collection of Blood From Patients With Cancer
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT00034216Older Breast Cancer Patients: Risk for Cognitive Decline
RecruitingObservational studyHealthy volunteers welcome
Ages 60 to 105 · Women · Updated Sep 28, 2026 · NCT03451383A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07060807An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07222267IKS014 in Advanced Solid Tumors That Express HER2
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05872295BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06120283Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Sep 28, 2026 · NCT05440929Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
Recruiting
Ages 18 to 90 · Women · Updated Sep 25, 2026 · NCT06294574Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05766891Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05528133A Study of Language Interpretation Solutions for People With Breast Cancer
Recruiting
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06721065The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RecruitingPhase 3
Ages 60 and older · All sexes · Updated Sep 25, 2026 · NCT06377852A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06103864A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
RecruitingPhase 2
Ages 18 and older · Women · Updated Sep 25, 2026 · NCT07054190A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06172478Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
Recruiting
Ages 30 and older · Women · Updated Sep 25, 2026 · NCT02945579From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.